BiotechTube
Wave Pharma

Wave Pharma

London, United Kingdom· Est.
wavepharma.co.uk
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.8M

Overview

Wave Pharma is a specialized service provider for the generic pharmaceutical sector, offering a comprehensive suite of regulatory, quality assurance, and supply chain services. Founded in 2013 and based in London, the company acts as an outsourced partner, enabling clients—particularly new market entrants—to navigate complex regulatory landscapes and achieve batch release and distribution in key territories. Its business model is built on deep industry expertise, providing services from product identification through to post-marketing surveillance, without developing its own therapeutic products.

Generic Drugs

Technology Platform

Integrated service platform combining regulatory strategy & submission expertise, quality & compliance (QP/RP) services, and licensed supply chain operations (importation, warehousing, batch release, distribution) for generic pharmaceuticals.

Funding History

1
Total raised:$2.8M
Seed$2.8M

Opportunities

The growing global generic drug market, driven by patent expiries and cost containment, creates sustained demand for outsourced regulatory and operational services.
Increasing regulatory complexity in the UK/EU post-Brexit presents a significant opportunity to serve companies lacking internal expertise.
Expansion into consulting for emerging markets and facility setup offers additional revenue streams.

Risk Factors

Revenue is contingent on the project-based demand from generic drug clients, creating cyclicality and client concentration risks.
The business faces severe reputational and operational risk from any compliance failure related to its regulatory licenses or client submissions.
It operates in a highly competitive market against larger CROs and niche consultants.

Competitive Landscape

Wave Pharma competes in the fragmented pharmaceutical services sector, facing competition from large global Contract Research Organizations (CROs) offering similar regulatory and QA services, as well as smaller niche consulting firms. Its key differentiation is the combination of high-level regulatory strategy with hands-on, licensed UK supply chain operations (MIA/WDA), a blend less common in pure consultancies.

More companies in United Kingdom →